Cornelia Mundt

Senior Principal Scientist at Agenus

Cornelia Mundt's Professional Contact Details

Email (Verified)

****@agenusbio.com

Get Email Address

(781) 674-4400

Location

Basel, Basel-Stadt, Switzerland

Company

Agenus

Person Seniority

senior

Person Functions

education

Cornelia Mundt's Current Company Details

Agenus

Lexington, Massachusetts, US • 194 Employees

biotechnology

Agenus is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer. By combining multiple powerful platforms, Agenus has established a highly integrated approach for the discovery, development and manufacture of monoclonal antibodies that modulate targets of interest. In addition, the Company's cancer vaccine program includes three proprietary platforms focused on individualized and off-the-shelf vaccines uniquely designed for each patient. Agenus' broad portfolio of novel checkpoint and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants work in combination to provide the opportunity to create best-in-class therapeutic regimens. The Company has formed collaborations with Merck and Incyte to discover and develop multiple checkpoint antibodies. For more information, please visit www.agenusbio.com; information that may be important to investors will be routinely posted on our website.

Public Symbol

AGEN

Founded Year

1994

Organization Website

agenusbio.com

Organization Languages

English

Organization Revenue

22600

Current Technologies

dns made easy